Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Jaxsta acquires Vampr, set to develop an online space for musicians and creators
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Jaxsta acquires Vampr, set to develop an online space for musicians and creators
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Jaxsta acquires Vampr, set to develop an online space for musicians and creators
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Jaxsta acquires Vampr, set to develop an online space for musicians and creators
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Jaxsta acquires Vampr, set to develop an online space for musicians and creators
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Jaxsta locks in deal with Spotify licensor Mechanical Licensing Collective
    Jaxsta locks in deal with Spotify licensor Mechanical Licensing Collective
    • News

  • Jaxsta’s symphony struggles to find its rhythm, employs third CEO in two years
    Jaxsta’s symphony struggles to find its rhythm, employs third CEO in two years
    • News

  • Vinyl is back, and Jaxsta is helming the revival
    Vinyl is back, and Jaxsta is helming the revival
    • News

  • Jaxsta acquires Vampr, set to develop an online space for musicians and creators
    Jaxsta acquires Vampr, set to develop an online space for musicians and creators
    • News

  • Beth Appleton revitalises Jaxsta revenue model to monetise its 116k user database
    Beth Appleton revitalises Jaxsta revenue model to monetise its 116k user database
    • News

  • FijiKava rejoices as ScoMo lifts import ban that has been in place since 2007
    • News

    FijiKava rejoices as ScoMo lifts import ban that has been in place since 2007

    The first time you drank beer, you probably thought it tasted like crap. But since that day, the amount of money you have spent on beer is probably insane for a drink you weren’t too keen on at the start. If you’ve been lucky enough to have travelled to Fiji, you probably had that same

    Read More
    Public
  • Aussies buying luxury goods online in droves as Cettire orders triple
    • News

    Aussies buying luxury goods online in droves as Cettire orders triple

    Prada, Armani, Fendi and Michael Kors – You don’t need to be strolling down streets of Milan or even finding parking space at Chadstone for a chance to show off fancy designer handbags or shoes. All you need to do is click a few buttons and arrive at Cettire (ASX: CTT) which is that thousands

    Read More
    Public
  • Everything happens for a riesling: Treasury Wines expands in the US with Napa Valley acquisition
    • News

    Everything happens for a riesling: Treasury Wines expands in the US with Napa Valley acquisition

    There are two non-negotiable beverages in my eyes: coffee and wine. At the end of the work day you will most likely find me firmly attached to the couch with a glass of red and a good book.  I have a feeling that the folks over at Treasury Wine Estates (ASX: TWE) are my type

    Read More
    Public
  • Viva Leisure deals increasingly more endorphins as lockdowns ease
    • News

    Viva Leisure deals increasingly more endorphins as lockdowns ease

    Not much compares to the endorphin kick you get after a great gym sesh. Yep, I don’t care what anyone else says, dragging yourself out of bed and into a gym to do endless burpees feels GOOD (when you’re done). Viva Leisure (ASX: VVA) is keen to become the endorphin dealer of choice for Aussies

    Read More
    Public
  • Global biotech funds commit $7.2m to breakthrough liver and bone cancer trials
    • News

    Global biotech funds commit $7.2m to breakthrough liver and bone cancer trials

    Breakthrough clinical trials into new treatments for bone marrow and liver cancer will soon commence after experienced institutional biotech investors with positive track records in companies such as Viralytics, Ophthea and Avita committed $7.2 million towards funding the trials for Pharmaxis (ASX: PXS) and their hero drug PXS-5505. Unlike other cancer treatment drugs on the

    Read More
    Public
  • Indentitii cashing in with $1m in service fees from investment in Payble
    • News

    Indentitii cashing in with $1m in service fees from investment in Payble

    Australia’s booming fintech industry continues to soar on the global stage with regulatory tech company Identitii (ASX: ID8) the latest to see it’s early stage investment in Payble gaining global attention which will secure $1m in service fees on top of their 39.3% equity stake in the startup. The $1m assignment fee will be payable

    Read More
    Public
  • ‘Culture of Success’ – 7 more clinics join Healthia’s fastest growing allied health portfolio
    • News

    ‘Culture of Success’ – 7 more clinics join Healthia’s fastest growing allied health portfolio

    Australia’s fastest growing allied health portfolio has increased further with Healthia (ASX: HLA) acquiring 7 new clinics to grow its national network of healthcare businesses to 293.  The acquisitions include five physiotherapy clinics (Physioworks) and one occupational therapy clinic (Scar Care) in Queensland, and one physiotherapy clinic (Eyre Sports Physiotherapy) in South Australia, expanding Healthia’s

    Read More
    Public
  • I just want (oat) milk that tastes like real milk
    • News

    I just want (oat) milk that tastes like real milk

    When it comes to plant based milks, oat milk reigns supreme (in my opinion at least). However, I often spend far too long standing in the supermarket aisle on my weekly shop deciding which one to buy… Before inevitably picking a selection to sample. Despite what might seem like a near saturated market, alternative milks

    Read More
    Public
  • Apiam partner receives approval to launch Xtend 21 Antimicrobial Surface Protectant across US veterinary markets
    • News

    Apiam partner receives approval to launch Xtend 21 Antimicrobial Surface Protectant across US veterinary markets

    The US Environmental Protection Agency has granted regulatory label approval for the commercialisation of Xtend 21®– an innovative product that has been demonstrated by university studies to enhance long term antimicrobial surface protection. The pathway of Xtend 21® for the US market first commenced in March 2020 when Apiam Animal Health (ASX: AHX) was appointed the exclusive

    Read More
    Public
  • Australian Clinical Labs tips over 1000 collection sites with new acquisition
    • News

    Australian Clinical Labs tips over 1000 collection sites with new acquisition

    Up 23% since their ASX debut in May earlier this year, Australian Clinical Labs (ASX: ACL) are expanding, with the acquisition of Medlab Pathology.  Medlab is a leading private pathology provider comprising two main laboratories and 288 collection sites across both NSW and QLD. The highly complementary acquisition will see ACL’s market share in NSW

    Read More
    Public
  • «
  • ‹
  • 210
  • 211
  • 212
  • 213
  • 214
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.